PHG
Koninklijke Philips N.V.
Medical - Devices
Market Cap$25.90B
5Y Perf.-34.0%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
PHG vs BAX
Revenue, margins, valuation, and 5-year total return — side by side.
BAX
Baxter International Inc.
Medical - Instruments & Supplies
Market Cap$8.77B
5Y Perf.-81.1%
PHG vs BAX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | PHG | BAX |
|---|---|---|
| Industry | Medical - Devices | Medical - Instruments & Supplies |
| Market Cap | $25.90B | $8.77B |
| Revenue (TTM) | $17.83B | $11.32B |
| Net Income (TTM) | $895M | $-1.10B |
| Gross Margin | 45.2% | 30.1% |
| Operating Margin | 8.0% | -2.7% |
| Forward P/E | 17.6x | 8.9x |
| Total Debt | $8.09B | $10.00B |
| Cash & Equiv. | $2.79B | $1.97B |
PHG vs BAX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
PHG
BAX
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Koninklijke Philips… (PHG) | 100 | 66.0 | -34.0% |
| Baxter Internationa… (BAX) | 100 | 18.9 | -81.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PHG vs BAX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: PHG leads in 5 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Baxter International Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
PHG
Koninklijke Philips N.V.
The Income Pick
PHG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.12, yield 1.5%
- 47.9% 10Y total return vs BAX's -43.5%
- Lower volatility, beta 1.12, Low D/E 73.6%, current ratio 1.32x
Best for: income & stability and long-term compounding
BAX
Baxter International Inc.
The Growth Play
BAX is the clearest fit if your priority is growth exposure and defensive.
- Rev growth 5.7%, EPS growth -37.8%, 3Y rev CAGR 3.8%
- Beta 1.37, yield 4.0%, current ratio 2.31x
- 5.7% revenue growth vs PHG's -1.0%
Best for: growth exposure and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | BAX | 5.7% revenue growth vs PHG's -1.0% |
| Value | BAX | Lower P/E (8.9x vs 17.6x) |
| Quality / Margins | PHG | 5.0% margin vs BAX's -9.7% |
| Stability / Safety | PHG | Beta 1.12 vs BAX's 1.37, lower leverage |
| Dividends | PHG | 1.5% yield, 1-year raise streak, vs BAX's 4.0% |
| Momentum (1Y) | PHG | +17.0% vs BAX's -42.1% |
| Efficiency (ROA) | PHG | 3.4% ROA vs BAX's -5.4%, ROIC 6.4% vs -1.4% |
PHG vs BAX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
PHG vs BAX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLPHGLAGGINGBAX
BAXBaxter International …
1leads
PHGKoninklijke Philips N…
4leads
6 Total Categories
CATEGORYLEADERvs BAXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
PHG4/6
Valuation MetricsMultiples, price ratios, and targets
BAX4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
PHG9/9
Total Returns1Y, 3Y, 5Y total returns with dividends
PHG6/6
Risk & VolatilityBeta, volatility, and downside exposure
PHG2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
PHG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PHG is the larger business by revenue, generating $17.8B annually — 1.6x BAX's $11.3B. PHG is the more profitable business, keeping 5.0% of every revenue dollar as net income compared to BAX's -9.7%.
| Metric | PHGKoninklijke Phili… | BAXBaxter Internatio… |
|---|---|---|
| RevenueTrailing 12 months | $17.8B | $11.3B |
| EBITDAEarnings before interest/tax | $2.5B | $671M |
| Net IncomeAfter-tax profit | $895M | -$1.1B |
| Free Cash FlowCash after capex | $755M | $501M |
| Gross MarginGross profit ÷ Revenue | +45.2% | +30.1% |
| Operating MarginEBIT ÷ Revenue | +8.0% | -2.7% |
| Net MarginNet income ÷ Revenue | +5.0% | -9.7% |
| FCF MarginFCF ÷ Revenue | +4.2% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.1% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.1% | -112.0% |
PHG leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
BAX leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, PHG's 10.7x EV/EBITDA is more attractive than BAX's 25.0x.
| Metric | PHGKoninklijke Phili… | BAXBaxter Internatio… |
|---|---|---|
| Market CapShares × price | $25.9B | $8.8B |
| Enterprise ValueMkt cap + debt − cash | $32.1B | $16.8B |
| Trailing P/EPrice ÷ TTM EPS | 24.95x | -9.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.59x | 8.90x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 10.73x | 24.97x |
| Price / SalesMarket cap ÷ Revenue | 1.24x | 0.78x |
| Price / BookPrice ÷ Book value/share | 2.03x | 1.43x |
| Price / FCFMarket cap ÷ FCF | 24.72x | 27.14x |
BAX leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
PHG leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
PHG delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-16 for BAX. PHG carries lower financial leverage with a 0.74x debt-to-equity ratio, signaling a more conservative balance sheet compared to BAX's 1.64x. On the Piotroski fundamental quality scale (0–9), PHG scores 7/9 vs BAX's 5/9, reflecting strong financial health.
| Metric | PHGKoninklijke Phili… | BAXBaxter Internatio… |
|---|---|---|
| ROE (TTM)Return on equity | +8.2% | -16.5% |
| ROA (TTM)Return on assets | +3.4% | -5.4% |
| ROICReturn on invested capital | +6.4% | -1.4% |
| ROCEReturn on capital employed | +7.1% | -1.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.74x | 1.64x |
| Net DebtTotal debt minus cash | $5.3B | $8.0B |
| Cash & Equiv.Liquid assets | $2.8B | $2.0B |
| Total DebtShort + long-term debt | $8.1B | $10.0B |
| Interest CoverageEBIT ÷ Interest expense | 4.34x | -0.83x |
PHG leads this category, winning 9 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
PHG leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PHG five years ago would be worth $5,814 today (with dividends reinvested), compared to $2,479 for BAX. Over the past 12 months, PHG leads with a +17.0% total return vs BAX's -42.1%. The 3-year compound annual growth rate (CAGR) favors PHG at 11.6% vs BAX's -24.8% — a key indicator of consistent wealth creation.
| Metric | PHGKoninklijke Phili… | BAXBaxter Internatio… |
|---|---|---|
| YTD ReturnYear-to-date | +0.6% | -12.9% |
| 1-Year ReturnPast 12 months | +17.0% | -42.1% |
| 3-Year ReturnCumulative with dividends | +39.2% | -57.4% |
| 5-Year ReturnCumulative with dividends | -41.9% | -75.2% |
| 10-Year ReturnCumulative with dividends | +47.9% | -43.5% |
| CAGR (3Y)Annualised 3-year return | +11.6% | -24.8% |
PHG leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
PHG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PHG is the less volatile stock with a 1.12 beta — it tends to amplify market swings less than BAX's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PHG currently trades 81.4% from its 52-week high vs BAX's 52.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | PHGKoninklijke Phili… | BAXBaxter Internatio… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 1.37x |
| 52-Week HighHighest price in past year | $33.44 | $32.68 |
| 52-Week LowLowest price in past year | $21.95 | $15.73 |
| % of 52W HighCurrent price vs 52-week peak | +81.4% | +52.0% |
| RSI (14)Momentum oscillator 0–100 | 40.5 | 41.4 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 8.7M |
PHG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — PHG and BAX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates PHG as "Hold" and BAX as "Hold". For income investors, BAX offers the higher dividend yield at 4.00% vs PHG's 1.47%.
| Metric | PHGKoninklijke Phili… | BAXBaxter Internatio… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | — | $19.75 |
| # AnalystsCovering analysts | 22 | 36 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +4.0% |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | $0.34 | $0.68 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Evenly matched — PHG and BAX each lead in 1 of 2 comparable metrics.
Key Takeaway
PHG leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BAX leads in 1 (Valuation Metrics). 1 tied.
Best OverallKoninklijke Philips N.V. (PHG)Leads 4 of 6 categories
Loading custom metrics...
PHG vs BAX: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is PHG or BAX a better buy right now?
For growth investors, Baxter International Inc.
(BAX) is the stronger pick with 5. 7% revenue growth year-over-year, versus -1. 0% for Koninklijke Philips N. V. (PHG). Koninklijke Philips N. V. (PHG) offers the better valuation at 24. 9x trailing P/E (17. 6x forward), making it the more compelling value choice. Analysts rate Koninklijke Philips N. V. (PHG) a "Hold" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PHG or BAX?
On forward P/E, Baxter International Inc.
is actually cheaper at 8. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PHG or BAX?
Over the past 5 years, Koninklijke Philips N.
V. (PHG) delivered a total return of -41. 9%, compared to -75. 2% for Baxter International Inc. (BAX). Over 10 years, the gap is even starker: PHG returned +47. 9% versus BAX's -43. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PHG or BAX?
By beta (market sensitivity over 5 years), Koninklijke Philips N.
V. (PHG) is the lower-risk stock at 1. 12β versus Baxter International Inc. 's 1. 37β — meaning BAX is approximately 23% more volatile than PHG relative to the S&P 500. On balance sheet safety, Koninklijke Philips N. V. (PHG) carries a lower debt/equity ratio of 74% versus 164% for Baxter International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PHG or BAX?
By revenue growth (latest reported year), Baxter International Inc.
(BAX) is pulling ahead at 5. 7% versus -1. 0% for Koninklijke Philips N. V. (PHG). On earnings-per-share growth, the picture is similar: Koninklijke Philips N. V. grew EPS 224. 0% year-over-year, compared to -37. 8% for Baxter International Inc.. Over a 3-year CAGR, BAX leads at 3. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PHG or BAX?
Koninklijke Philips N.
V. (PHG) is the more profitable company, earning 5. 0% net margin versus -8. 5% for Baxter International Inc. — meaning it keeps 5. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PHG leads at 8. 0% versus -2. 7% for BAX. At the gross margin level — before operating expenses — PHG leads at 45. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PHG or BAX more undervalued right now?
On forward earnings alone, Baxter International Inc.
(BAX) trades at 8. 9x forward P/E versus 17. 6x for Koninklijke Philips N. V. — 8. 7x cheaper on a one-year earnings basis.
08Which pays a better dividend — PHG or BAX?
All stocks in this comparison pay dividends.
Baxter International Inc. (BAX) offers the highest yield at 4. 0%, versus 1. 5% for Koninklijke Philips N. V. (PHG).
09Is PHG or BAX better for a retirement portfolio?
For long-horizon retirement investors, Koninklijke Philips N.
V. (PHG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 12), 1. 5% yield). Both have compounded well over 10 years (PHG: +47. 9%, BAX: -43. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PHG and BAX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PHG is a mid-cap quality compounder stock; BAX is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(PHG: 1.1% · BAX: 2.9%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.